Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
Quiralte J, Delgado J, Sáenz de San Pedro B, López-Pascual E, Nieto MA, Ortega N, Florido JF, Conde J. Quiralte J, et al. Among authors: lopez pascual e. Ann Allergy Asthma Immunol. 2004 Oct;93(4):360-4. doi: 10.1016/s1081-1206(10)61395-6. Ann Allergy Asthma Immunol. 2004. PMID: 15521372 Clinical Trial.
Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: lopez pascual e. Biomed Pharmacother. 2024 Jun;175:116813. doi: 10.1016/j.biopha.2024.116813. Epub 2024 May 24. Biomed Pharmacother. 2024. PMID: 38789350 Free article. No abstract available.
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: lopez pascual e. Biomed Pharmacother. 2024 May;174:116530. doi: 10.1016/j.biopha.2024.116530. Epub 2024 Apr 3. Biomed Pharmacother. 2024. PMID: 38574623 Free article. Review.
Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden.
Revert F, Revert-Ros F, Blasco R, Artigot A, López-Pascual E, Gozalbo-Rovira R, Ventura I, Gutiérrez-Carbonell E, Roda N, Ruíz-Sanchis D, Forteza J, Alcácer J, Pérez-Sastre A, Díaz A, Pérez-Payá E, Sanz-Cervera JF, Saus J. Revert F, et al. Among authors: lopez pascual e. Oncotarget. 2018 Jan 19;9(13):11020-11045. doi: 10.18632/oncotarget.24280. eCollection 2018 Feb 16. Oncotarget. 2018. PMID: 29541394 Free PMC article.
Mutations in the Caenorhabditis elegans orthologs of human genes required for mitochondrial tRNA modification cause similar electron transport chain defects but different nuclear responses.
Navarro-González C, Moukadiri I, Villarroya M, López-Pascual E, Tuck S, Armengod ME. Navarro-González C, et al. Among authors: lopez pascual e. PLoS Genet. 2017 Jul 21;13(7):e1006921. doi: 10.1371/journal.pgen.1006921. eCollection 2017 Jul. PLoS Genet. 2017. PMID: 28732077 Free PMC article.
Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).
Revert-Ros F, López-Pascual E, Granero-Moltó F, Macías J, Breyer R, Zent R, Hudson BG, Saadeddin A, Revert F, Blasco R, Navarro C, Burks D, Saus J. Revert-Ros F, et al. Among authors: lopez pascual e. J Biol Chem. 2011 Oct 7;286(40):35030-43. doi: 10.1074/jbc.M111.249458. Epub 2011 Aug 9. J Biol Chem. 2011. PMID: 21832087 Free PMC article.